AGIO Agios Pharmaceuticals Inc.


401,092 Shares Traded
860,439 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $477.28 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-36.74%
If Intiated One Month Ago, Shorts Have Realized a Return of:-4.42%
If Initiated Five Days ago, Shorts Have Realized a Return of:-3.83%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 10.71%
Short Interest6.07 million
Float56.62 million
Short Ratio6.24
Market Cap$4.69 billion
Market Maker ActivityDaily Short Volume


Biotechs: Still Well Placed For More Gains (SeekingAlpha)
Your Daily Pharma Scoop: AbbVie's Upadacitinib, Johnson & Johnson's Tremfya, Celgene Reports Results For Otezla (SeekingAlpha)
3 Things In Biotech You Should Learn Today: February 18, 2018 (SeekingAlpha)
Celgene's Otezla-Colitis Story; Implications For Other Biotechs (SeekingAlpha)
FDA accepts Agios Pharma's marketing application for ivosidenib for AML (SeekingAlpha)
Agios Pharmaceuticals' (AGIO) CEO Dr. David Schenkein on Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
Agios Pharmaceuticals, Inc. 2017 Q4 - Results - Earnings Call Slides (SeekingAlpha)
Agios Pharmaceuticals misses by $0.15, misses on revenue (SeekingAlpha)
Notable earnings before Wednesday's open (SeekingAlpha)
Biotech Developer Stock Price Risks & Returns: An Understanding Today (SeekingAlpha)

Earnings Stats

PE Ratio -12.14
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $61.61
50 Day Moving Average $68.65
52 Week High $83.92
52 Week Low $45.11

Data provided for free by IEX. Questions? Read the FAQ